Direxion Daily S&P Biotech Bull 3X ETF (LABU)
NYSEARCA: LABU · Real-Time Price · USD
210.02
-0.76 (-0.36%)
Oct 14, 2026, 4:00 PM EDT - Market closed
LABU Holdings Information
LABU is an equity ETF with a total of 173 individual holdings. The top holdings are SPSIBI SWAP ASSET LEG stock at 218.73%, GOLDMAN FINL SQ TRSRY INST 506 at 24.39%, DREYFUS GOVT CASH MAN INS at 2.96%, Moderna at 2.00%, and Twist Bioscience at 1.51%.
Total Holdings
173
Top 10 Percentage
248.08%
Asset Class
Equity
ETF Category
Trading--Leveraged Equity
Assets
620.15M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | SPSIBI SWAP ASSET LEG | 52.55% |
| 2 | n/a | SPSIBI SWAP ASSET LEG | 47.86% |
| 3 | n/a | SPSIBI SWAP ASSET LEG | 40.92% |
| 4 | n/a | SPSIBI SWAP ASSET LEG | 38.00% |
| 5 | n/a | SPSIBI SWAP ASSET LEG | 32.21% |
| 6 | n/a | GOLDMAN FINL SQ TRSRY INST 506 | 24.39% |
| 7 | n/a | SPSIBI SWAP ASSET LEG | 4.35% |
| 8 | n/a | DREYFUS GOVT CASH MAN INS | 2.96% |
| 9 | n/a | SPSIBI SWAP ASSET LEG | 2.84% |
| 10 | MRNA | Moderna, Inc. | 2.00% |
| 11 | TWST | Twist Bioscience Corporation | 1.51% |
| 12 | NTRA | Natera, Inc. | 1.50% |
| 13 | IOVA | Iovance Biotherapeutics, Inc. | 1.39% |
| 14 | ABBV | AbbVie Inc. | 1.37% |
| 15 | BIIB | Biogen Inc. | 1.36% |
| 16 | UTHR | United Therapeutics Corporation | 1.35% |
| 17 | AMGN | Amgen Inc. | 1.32% |
| 18 | HALO | Halozyme Therapeutics, Inc. | 1.28% |
| 19 | EXEL | Exelixis, Inc. | 1.28% |
| 20 | GILD | Gilead Sciences, Inc. | 1.27% |
| 21 | TGTX | TG Therapeutics, Inc. | 1.25% |
| 22 | PTGX | Protagonist Therapeutics, Inc. | 1.19% |
| 23 | GRAL | GRAIL, Inc. | 1.17% |
| 24 | REGN | Regeneron Pharmaceuticals, Inc. | 1.17% |
| 25 | VRTX | Vertex Pharmaceuticals Incorporated | 1.17% |
As of Oct 14, 2026